Pharmaron Beijing Co., Ltd. (SHE: 300759)

Market Cap	41.21B
Revenue (ttm)	11.80B
Net Income (ttm)	1.88B
Shares Out	1.77B
EPS (ttm)	1.06
PE Ratio	23.75
Forward PE	27.11
Dividend	0.20 (0.80%)
Ex-Dividend Date	Jun 27, 2024

Volume	11,089,325
Average Volume	13,885,001
Open	25.28
Previous Close	24.85
Day's Range	24.85 - 25.39
52-Week Range	17.70 - 36.42
Beta	0.88
RSI	45.54
Earnings Date	Mar 27, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 20,295
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300759

Financial Performance

In 2023, Pharmaron Beijing's revenue was 11.54 billion, an increase of 12.39% compared to the previous year's 10.27 billion. Earnings were 1.60 billion, an increase of 16.48%.